check on YTD, 12 months, 5 years, 10 years, 20 years and get back to us on what you find. Hint: it's not so good except against LJPC, a terrible company.
sure, he sold because the company is being acquired. Unless they are being acquired for $4, that would be a stupid sale. Well, he is not so bright, so maybe you are on to something.
Yes, since they only have one strength, discovery and very early development, they don't need so many employees burning up the cash, they can wait for their partnerships to mature, partner everything out, reduce costs and either buy back stock or pay a dividend when the cash flow starts building, or just find a buyer and sell off the parts that the buyer does not want. This company should easily be worth $2BB+ (sum of parts) if SGEN is worth $5BB. They also have losses that can be carried forward to provide tax free income from Kadcyla revs.
Yesterday there was a lot of back slapping and optimism over holding up fairly well in a bad market. This morning a lot of "bought more, added"...A bottom will be formed when investors are more negative. Not there yet. Now at IMGN and ARNA, investors are already there, ready for a CEO lynching.
Do you think the IMGN exec team is heading in the right direction, doing a good job, having success, creating shareholder value, making sound business decisions? I say Heck No and it's past time for a change. Dan must go and then be replaced by Howard Pien, or someone else with a track record of success, or turnaround and sale. All shareholders should take action to push for change.
Through my job I frequently talk to MR pros and every once in awhile I run into someone working in an area of interest. Anyway, I asked her what she thought about the other obesity drugs and the only one she was positive on was Belviq, for weight loss and glucose control, she was more focused on products for diabetes and pre-diabetes. FWIW, a minor positive, N of 1.
I have been trying to get the attention of this do-nothing BOD, perhaps I should switch my focus to contacting Bus Dev pros at Sanofi and Roche to start the bidding. I will not rest until the IMGN shareholders and shareholder value becomes the focus of IMGN executives and the BOD, who are only focused on personal wealth/ value.
Keep pumping, the sub $4 shorts are looking better than the over $8 longs at this point. They have the momentum and Jack on their side.
Jack has bought off the BOD with a huge stock package, so he will be difficult to replace. The BOD all took a $15,000 hair cut on those recent, lavish stock grants.
You may have noticed, the BOD have switched from options to stock, because options can become worthless when a stock fails to increase. Great work from the BOD and Jack!
To this I say B.S. He certainly couls have placed price restrictions on the trade, don't sell under $x. The real problem is he's either clueless about his actions, or does not care. Take your pick, either one is a reason for his being replaced.
that's great news, more selling to come from Jack then? This sale was a great success. The only ironic and somewhat humorous thing is Jack cost everyone, even the BOD 10% today. Jack needs a new boat, or a new cottage, everyone pays 10%. Jack has a business savvy impediment.
they would fit nicely with Shire and LLY, or even Abbvie, which has a few CNS assets. Don't see Allergan happening, but they could buy the partnered assets if ACAD is acquired. Those assets + the cash would lighten the risk and cost a little. Still shooting for $40 in a takeover, but would be OK at $35 this year, more if/after approval. Overseas partner deal could add more cash, or they might just take a high sales royalty, or some combo.
Who knows, but IMGN seems to only have one direction, down. The BOD must take action. All shareholders must apply pressure. IMGN sum of parts must be worth at least 50-100% more than the current valuation. I am tired of waiting, Junius needs to go NOW!
He's not CEO material, never has been, he's destroying shareholder value and confidence. Take a seat on the board, go fishing, but hire a business person as President and CEO. This is getting OLD!
Thanks Jack for helping make a new YTD low and heading toward a critical test of $5.5. Shorts will have an easy time covering all they want now thanks to the selfish, non-business savvy, poor communicating CEO. Please retire Jack and find a business person to run the company.